Ashby J. and Paton D. (1995). Chemicals for evaluating the sensitivity and specificity of reduced/transgenic rodent cancer bioassay products. Mutation Res. 331: 27-38.
2.
Ashby J., Short JM, Jones NJ, Lefevre PA, Provost GS, Rogers BJ, Martin LA, Parry JM, Burnette K., Glickman BW, and Tinwell H. (1994). Mutagenicity of o-anisidine to the bladder of lacI- transgenic B6C3F1 mice: Absence of 14C or 32P bladder DNA adduction . Carcinogenesis15(10): 2291-2296.
3.
Tennant RW, French JE, and Spalding JW (1995). Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ. Health Perspect. 103(10): 942-951.